AnaptysBio, Inc.
AnaptysBio, Inc. (ANAB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ANAB · as of Jun 8, 2026
Key Statistics
Explore AnaptysBio, Inc. Data
anab stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 22 · Buy rate: 72.7%
The ANAB analyst consensus is Buy, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $83.14, representing +59.81% upside from the current price of $52.02.
Competitors & Peers
anab competitorsANAB
BBOT
DNTH
KOD
MNMD
NRIXStock Performance
Full HistoryAbout AnaptysBio, Inc.
AnaptysBio, Inc. a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an an…
what is anaptysbio, inc. · anab stock overview · anaptysbio, inc. company profile · who is anaptysbio, inc. ceo · anab NASDAQ · anaptysbio, inc. headquarters · anaptysbio, inc. business segments
About Stock Overview & Key Data
AnaptysBio, Inc. (ANAB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 26, 2017. As of the latest trading session, ANAB stock price is $52.02, with a market capitalization of $2.2B. The stock has returned +225.81% over the past 12 months and +55.85% year-to-date.
According to 22 Wall Street analysts, the consensus rating for AnaptysBio, Inc. stock is Buy, with an average 12-month price target of $83.14. In fiscal year 2025, AnaptysBio, Inc. reported revenue of $234.6M and net income of -$13.2M. For detailed data — including AnaptysBio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AnaptysBio, Inc. (ANAB) stock price is $52.02. The stock is traded on NASDAQ under the ticker symbol ANAB. The 52-week range is $11.40 – $72.36.